Fukumoto Ichiro, Koshizuka Keiichi, Hanazawa Toyoyuki, Kikkawa Naoko, Matsushita Ryosuke, Kurozumi Akira, Kato Mayuko, Okato Atsushi, Okamoto Yoshitaka, Seki Naohiko
Department of Functional Genomics, Chiba University Graduate School of Medicine, Chuo-ku, Chiba 260-8670, Japan.
Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chuo-ku, Chiba 260-8670, Japan.
Int J Oncol. 2016 Sep;49(3):1119-29. doi: 10.3892/ijo.2016.3602. Epub 2016 Jul 4.
Our recent studies of microRNA (miRNA) expression signatures in human cancers revealed that two clustered miRNAs, microRNA-23b (miR-23b) and microRNA-27b (miR‑27b), were significantly reduced in cancer tissues. Few reports have provided functional analyses of these clustered miRNAs in oral squamous cell carcinoma (OSCC). The aim of this study was to investigate the functional significance of miR-23b and miR-27b in OSCC and to identify novel miR-23b/27b-mediated cancer pathways and target genes involved in OSCC oncogenesis and metastasis. Expression levels of miR-23b and miR-27b were significantly reduced in OSCC specimens. Restoration of miR-23b or miR-27b in cancer cells revealed that both miRNAs significantly inhibited cancer cell migration and invasion. Our in silico analyses and luciferase reporter assays showed that the receptor tyrosine kinase MET, was directly regulated by these miRNAs. Moreover, downregulating the MET gene by use of siRNA significantly inhibited cell migration and invasion by OSCC cells. The identification of novel molecular pathways regulated by miR-23b and miR-27b may lead to a better understanding of the oncogenesis and metastasis of this disease.
我们最近对人类癌症中微小RNA(miRNA)表达特征的研究表明,两个成簇的miRNA,即微小RNA-23b(miR-23b)和微小RNA-27b(miR-27b),在癌组织中显著减少。很少有报告对口腔鳞状细胞癌(OSCC)中这些成簇的miRNA进行功能分析。本研究的目的是探讨miR-23b和miR-27b在OSCC中的功能意义,并确定参与OSCC发生和转移的新的miR-23b/27b介导的癌症途径和靶基因。在OSCC标本中,miR-23b和miR-27b的表达水平显著降低。在癌细胞中恢复miR-23b或miR-27b显示,这两种miRNA均显著抑制癌细胞的迁移和侵袭。我们的计算机分析和荧光素酶报告基因检测表明,受体酪氨酸激酶MET受这些miRNA直接调控。此外,使用小干扰RNA(siRNA)下调MET基因可显著抑制OSCC细胞的迁移和侵袭。对miR-23b和miR-27b调控的新分子途径的鉴定可能有助于更好地理解该疾病的发生和转移。